El IOZK es un centro traslacional y desarrolla procedimientos inmuno-oncológicos sobre la base de nuevos descubrimientos científicos.
Éstos se combinan de la mejor manera posible para cada paciente. Por este motivo, en el IOZK no se realizan ensayos clínicos aleatorios. Éstos requieren el mismo protocolo de tratamiento para todos los pacientes del grupo experimental y un grupo de comparación que no recibe ningún tratamiento. En la comunidad científica se están desarrollando y debatiendo nuevos métodos de investigación más adecuados para investigar la eficacia de una terapia altamente individualizada. Para nosotros es muy importante contribuir al progreso científico y al desarrollo de la inmunoterapia moderna contra las enfermedades tumorales.
Aquí ofrecemos artículos científicos publicados por empleados del IOZK.
Más enlaces sobre el tema:
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
El IOZK
La inmunoterapia IOZK
Noticias y publicaciones internacionales
- The Complexity of Malignant Glioma Treatment
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
The Complexity of Malignant Glioma Treatment
/in Dendritic Cells, Glioblastoma, Hyperthermia, Immunogenic Cell Death, International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusIndividualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution
/in International Publications, IOZK Aktuelles, IOZK VeröffentlichungenNueva publicación del IOZK sobre biopsia líquida
/in IOZK Aktuelles, IOZK VeröffentlichungenMethods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen, Newcastle Disease VirusDendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Aktuelles, IOZK VeröffentlichungenThe Application of Evidence-Based Medicine in Individualized Medicine
/in International Publications, IOZK VeröffentlichungenIndividualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
/in Dendritic Cells, Glioblastoma, International Publications, IOZK VeröffentlichungenStefaan van Gool es editor de un número especial del Journal of Molecular Sciences
/in Brain Tumors in Children, IOZK Aktuelles, IOZK VeröffentlichungenCounteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
/in International Publications, IOZK VeröffentlichungenPosterpräsentation auf der Jahrestagung der Association for Cancer Immunotherapy
/in Glioblastoma, International Publications, IOZK bei Fachtagungen, IOZK VeröffentlichungenSynergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusStem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors
/in International Publications, IOZK VeröffentlichungenDNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival
/in Glioblastoma, International Publications, IOZK VeröffentlichungenImpaired DNA repair in mouse monocytes compared to macrophages and precursors
/in International Publications, IOZK VeröffentlichungenRandomized Controlled Immunotherapy Clinical Trials for GBM Challenged
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusMitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism
/in International Publications, IOZK VeröffentlichungenEvidence-Based Medicine in Oncology: Commercial Versus Patient Benefit
/in International Publications, IOZK VeröffentlichungenPosition paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusUn análisis de IOZK muestra la buena tolerabilidad de la inmunoterapia con IOZK en el glioma pontino intrínseco difuso (DIPG)
/in IOZK VeröffentlichungenAddition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience
/in Brain Tumors in Children, Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus